Decibel Therapeutics
NEWS
As FDA seeks to rehire some fired employees, Donald Trump threatens to enact tariffs on pharma companies unless they reshore manufacturing; another lawsuit hits the complex GLP-1 compounding space as Eli Lilly offers expanded Zepbound options; and struggling gene therapy biotech bluebird bio goes private in an attempt to stay solvent.
The acquisition will bring gene therapy company Decibel Therapeutics into Regeneron’s fold after a six-year partnership, targeting different forms of congenital and monogenic hearing loss.
Like almost all conferences this year, Citi’s 15th Annual BioPharma Conference 2020 is being held virtually.
Pharma and biotech companies strengthen their leadership teams and boards with this week’s Movers & Shakers.
Biotech and pharma companies tap new members of executive leadership teams and boards.
In this week’s edition of Movers and Shakers, biopharma companies tap executives to serve in various leadership roles.
Among life on earth, mammals are some of the only creatures that can’t regenerate damaged hearing. Birds, frogs, fish, they all have the ability to regenerate sensory hair cells after they’re damaged.
Venture capitalists are flexing their muscles today with the significant support of pharma and biotech companies.
JOBS
IN THE PRESS